Evidence map›Paper›PMID 41894455›Full record

ArticlePloS one2026

Establishment of an in vitro hairless guinea pig dermal model.

Samantha Emma Sarles, Priscilla Lee, Linnzi Wright, Daniel Angelini

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samantha Emma SarlesUnited States of America Army, Combat Capabilities Command (DEVCOM) Chemical Biological Center, Aberdeen Proving Grounds, Maryland, United States of America.ORCID https://orcid.org/0000-0003-4890-1820
Priscilla LeeUnited States of America Army, Combat Capabilities Command (DEVCOM) Chemical Biological Center, Aberdeen Proving Grounds, Maryland, United States of America.
Linnzi WrightUnited States of America Army, Combat Capabilities Command (DEVCOM) Chemical Biological Center, Aberdeen Proving Grounds, Maryland, United States of America.
Daniel AngeliniUnited States of America Army, Combat Capabilities Command (DEVCOM) Chemical Biological Center, Aberdeen Proving Grounds, Maryland, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hairless guinea pigs (HGP) make a desirable model for percutaneous exposure because they do not need to be clipped and are lower in cost and less sentient than swine. Current data leaves gaps in data translation and scaling from animal to human and from cells to whole organisms. The establishment and tracking of in vitro cell cultures from animals from an in-house colony allows for highly controllable and reportable data for data translation. We report the isolation, culture, methods optimization, characterization, and toxicant exposure of HGP dermal fibroblasts (HGP-DF) from the in-house HGP breeding colony at U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC). We successfully isolated HGP-DF from the forelimb and hindlimb skin of several HGP. Fibroblasts exited tissue within 14 days. All trypsin and media types tested for cell maintenance yielded cells with greater than 95% viability during passaging. Cells were stored under cryopreservation and exhibited acceptable viability for several passages after thawing. Fluorescently stained HGP-DF exhibited similar morphology as vendor certified human dermal fibroblasts. HGP-DF were more sensitive than human dermal fibroblasts to a toxic exposure, with median lethal concentrations of 1 mM and 0.3 mM for human cells and hairless guinea pig cells, respectively. This follows a similar trend as observed in whole organism data from the same toxicant. This work marks the first documented protocol on isolation, culture, characterization, and exposure of HGP cells. HGP-DF enable an intermediate model between human cells and in vivo models that may enable validation of in vitro models against animal models. Future work should address limitations of the present study, including evaluating phenotypic changes of cells following cryopreservation and immunohistochemistry compared to vendor certified controls to confirm dermal fibroblast phenotype.

Indexed as

DermisFibroblastsSkinAnimalsCell Culture TechniquesCells, CulturedCell SurvivalFemaleGuinea PigsHumansModels, Animal

Identifiers

PMID41894455
PMCPMC13028373

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.